Prothrombin complex concentrate in the treatment of multitransfusion dilutional coagulopathy in a paediatric patient

British Journal of Anaesthesia

Volumn 106, Issue 6, 2011, Pages 912-913

  Fuentes Garca, D ^a   Hernndez Palazn, J ^a   Sansano Snchez, T ^a   Acosta Villegas, F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

OCTAPLEX; PROTHROMBIN COMPLEX; UNCLASSIFIED DRUG;

BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CASE REPORT; HUMAN; INFANT; LABORATORY TEST; LETTER; NEWBORN INTENSIVE CARE; PRIORITY JOURNAL; ULTRASOUND;

EID: 79957522907     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aer140     Document Type: Letter

References (6)

1. Hellstern P, Halbmayer WM, Kohler M, et al. Prothrombin complex concentrates: indications, contraindications, and risks: a task force summary. Thromb Res 1999; 95: S3-6 (Pubitemid 29461041)
2. Franchini M, Lippi G. Prothrombin complex concentrates: an update. Blood Transfus 2010; 8: 149-54
3. Makris M. Optimisation of the prothrombin complex concentrate dose for warfarin reversal. Thromb Res 2005; 115: 451-3 (Pubitemid 40409976)
4. Staudinger T, Frass M, Rintelen C, et al. Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients. Intensive Care Med 1999; 25: 1105-10 (Pubitemid 29525066)
5. Lorenz R, Kienast J, Otto U, et al. Efficacy and safety of a prothrombin complex concentrate with two virusinactivation steps in patients with severe liver damage. Eur J Gastroenterol Hepatol 2003; 15: 15-20 (Pubitemid 36135657)
6. Meeks SL, Abshire TC. Abnormalities of prothrombin: a review of the pathophysiology, diagnosis, and treatment. Haemophilia 2008; 14: 1159-63